Potential Therapeutic Candidates against Chlamydia pneumonia Discovered and Developed In Silico Using Core Proteomics and Molecular Docking and Simulation-Based Approaches

Medicine and Dentistry

• Chlamydophila pneumoniae 100%
• Proteome 100%
• Proteomics 100%
• Target Protein 66%
• 4 Hydroxybenzoic Acid 33%
• Asthma 33%
• Cytoplasm Protein 33%
• Core Protein 33%
• Arthritis 33%
• Protein Binding 33%
• Phytochemical 33%
• Ribosome Protein 33%
• Carboxylyase 33%
• Inflammatory Disorder 33%
• Oligopeptide 33%
• Persistent Infection 33%

Immunology and Microbiology

• Molecular Docking 100%
• Proteomics 100%
• Chlamydia pneumoniae 100%
• Arthritis 33%
• Oligopeptide 33%
• Bioinformatics 33%
• Asthma 33%
• Protein Binding 33%
• Cellular Distribution 33%
• Inflammatory Disorder 33%

Biochemistry, Genetics and Molecular Biology

• Proteome 100%
• Chlamydia pneumoniae 100%
• Subcellular Localization 33%
• Carboxy-Lyases 33%
• Bioinformatics 33%
• Binding Protein 33%
• Ribosomal Protein 33%
• 30S 33%
• Oligopeptide 33%